Entity Address, City or Town Entity Address, City or Town Deferred tax liabilities: Deferred Tax Liabilities, Net [Abstract] Schedule of Reconciliations of the Expected Statutory Federal Income Tax Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Warrant Two [Member] Warrant Two [Member] Warrant two. Operating lease, lease not yet commenced, extension term Lessee, Operating Lease, Lease Not yet Commenced, Renewal Term Issuance of common stock upon release of restricted stock units, Shares Issuance Of Common Stock Upon Exercise Of Options And Release Of Restricted Stock Units Share Issuance of common stock upon exercise of options and release of restricted stock units share. Fair Value Disclosures [Abstract] Common Stock Options and Restricted Stock Units [Member] Common Stock Options And Restricted Stock Units [Member] Common stock options and restricted stock units. Earnings Per Share [Abstract] Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] Fair Value, Inputs, Level 1 [Member] Summary of Accrued Expenses Schedule of Accrued Liabilities [Table Text Block] 2025 Finance Lease, Liability, to be Paid, Year Three Federal [Member] Domestic Tax Authority [Member] Research and Development Costs Research and Development Expense, Policy [Policy Text Block] Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Amendment Flag Amendment Flag Total grant date fair value of restricted stock units vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Prepaid Clinical and Research Expense [Member] Prepaid Clinical And Research Expense [Member] Prepaid clinical and research expense. Subsequent Event Type [Domain] Other Prepaid Expenses [Member] Other Prepaid Expenses [Member] Other prepaid expenses. Operating lease, right-of-use assets Operating Lease, Right-of-Use Asset NOLs carryforwards not subject to expiration Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration Less: Amount representing interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Net Loss Per Share Earnings Per Share, Policy [Policy Text Block] Statement [Table] Statement [Table] Long-term operating lease liability, net of current portion Operating Lease, Liability, Noncurrent 2023 Finance Lease, Liability, to be Paid, Year One Common Stock Warrants [Member] Common Stock Warrants [Member] Warrants For Common Stock [Member] Warrants for common stock. Proceeds from issuance of common stock through underwritten follow on offering net of offering costs. Proceeds from issuance of common stock from underwritten follow-on offering, net of offering costs Proceeds From Issuance Of Common Stock Through Underwritten Follow On Offering Net Of Offering Costs Issuance of common stock pursuant to employee stock purchase plan, Shares Stock Issued During Period, Shares, Employee Stock Purchase Plans Number of operating segment Number of Operating Segments Preferred Stock, Shares Outstanding, Ending Balance Preferred Stock, Shares Outstanding, Beginning Balance Preferred stock, shares outstanding Preferred Stock, Shares Outstanding Maturity period of investment securities Available For Sale Securities Debt Securities Maturity Period Available for sale securities debt securities maturity period. Cash and Cash Equivalents and Restricted Cash Cash And Cash Equivalents and Restricted Cash Policy [Policy Text Block] Cash and cash equivalents and restricted cash policy. Number of common stock shares reserved for issuance Common stock reserved for future issuance Common Stock, Capital Shares Reserved for Future Issuance Auditor Firm ID Auditor Firm ID Summary of Common Stock Reserved for Future Issuance Schedule Of Common Stock Reserved For Future Issuance Table [Text Block] Schedule of common stock reserved for future issuance. Weighted Average Grant Date Fair Value, Beginning Balance Weighted Average Grant Date Fair Value, Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Milestone payment triggered amount Milestone Payment Triggered Amount Milestone payment triggered amount. Income Tax Authority Income Tax Authority [Domain] Number of Outstanding Stock Options, Canceled/forfeited/expired Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Total Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Product and Service Product and Service [Axis] License and Collaboration Revenues [Member] License and Collaboration Revenues. ESPP [Member] Employee Stock [Member] Cash, cash equivalents and available-for-sale investments Cash And Cash Equivalents And Available For Sale Investments Cash and cash equivalents and available for sale investments. Commitments and Contingencies Disclosure [Table] Commitments and contingencies disclosure. Employee-related Liabilities, Current, Total Accrued salaries, wages and benefits Employee-related Liabilities, Current Employee Stock Option [Member] Share-Based Payment Arrangement, Option [Member] Operating lease, weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Total liabilities and stockholders’ equity Liabilities and Equity Right of use lease assets Deferred Tax Liabilities, Leasing Arrangements Plan Name Plan Name [Domain] Schedule of Prepaid Expenses Schedule Of Prepaid Expenses Table [Text Block] Schedule of prepaid expenses. Less: Tenant improvement allowance not yet received Lessee Operating Lease Liability Tenant Improvement Allowance Not Yet Received Lessee operating lease liability tenant improvement allowance not yet received. Denominator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Hong Kong [Member] HONG KONG Base rent amortized percentage Base Rent Amortized Percentage Base rent amortized percentage Leases, Operating [Abstract] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Income Statement [Abstract] Proceeds from issuance of common stock through registered direct offering, net of offering costs Proceeds From Issuance Of Common Stock Through Registered Direct Offering Net Of Offering Costs Proceeds from issuance of common stock through registered direct offering, net of offering costs. Liquidity and Financial Condition Liquidity And Financial Condition Policy [Text Block] Liquidity and financial condition. Financing lease, weighted-average remaining lease term Finance Lease, Weighted Average Remaining Lease Term Effective date of plan Effective Date Of Plan Effective date of plan. Less: Current portion of financing lease liability Current portion of financing lease liability Finance Lease, Liability, Current Sale of Stock Sale of Stock [Domain] Unrealized gain between amortized cost and fair value of investment securities Unrealized Gain Loss On Amortized Cost And Fair Value Of Investment Securities Unrealized gain (loss) on amortized cost and fair value of investment securities. Total current liabilities Liabilities, Current Commission Rate Equal To Gross Proceeds1 Commission Rate Equal To Gross Proceeds1 Commission rate equal to gross proceeds. Issuance of common stock pursuant to employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan NOLs carryforwards Operating Loss Carryforwards 2025 Lessee, Operating Lease, Liability, to be Paid, Year Three Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest, Total Comprehensive loss attributable to noncontrolling interest in Pangu BioPharma Limited Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Fair Value, Measurements, Recurring [Member] Fair Value, Recurring [Member] Share-based Payment Arrangement, Tranche Two Share-Based Payment Arrangement, Tranche Two [Member] Income Taxes Income Tax, Policy [Policy Text Block] Contract liability Increase (Decrease) in Contract with Customer, Liability Preferred stock, shares authorized Preferred Stock, Shares Authorized Deferred Tax Liabilities, Net, Total Total deferred tax liabilities Deferred Tax Liabilities, Net 2015 Employee Stock Purchase Plan [Member] Two Thousand Fifteen Employee Stock Purchase Plan [Member] 2015 Employee Stock Purchase Plan. Other Receivables, Net, Current, Total Other receivables Other Receivables, Net, Current Increase (decrease) related to prior year tax positions Unrecognized Tax Benefits Increase Decrease Resulting From Prior Period Tax Positions Unrecognized tax benefits increase (decrease) resulting from prior period tax positions. Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Operating lease, weighted average discount rate Operating Lease, Weighted Average Discount Rate, Percent Finance Lease, Liability [Abstract] Entity Small Business Entity Small Business Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Stock-Based Compensation Compensation Related Costs, Policy [Policy Text Block] Investments Investments [Domain] Lease space Area of Land Total current assets Assets, Current Property Plant And Equipment [Line Items] Property, Plant and Equipment [Line Items] Shares used in computing net loss per share, basic Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Basic, Total Present value of lease payments Finance Lease, Liability City Area Code City Area Code Aggregate Intrinsic Value, Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Weighted Average Grant Date Fair Value, Released Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Released In Period Weighted Average Grant Date Fair Value Share based compensation arrangement by share based payment award, equity instruments other than options, released in period, weighted average grant date fair value. Restricted Cash [Member] Restricted Cash Member Restricted Cash Member Share-Based Payment Arrangement [Abstract] Document Period End Date Document Period End Date Asset-backed Securities [Member] Asset-Backed Securities [Member] Percentage threshold of outstanding shares as of December 31 of each year for calculation of annual increase in authorized shares under the plan Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum Share-based compensation expense Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost Defined Contribution Plan Disclosure [Line Items] Defined Contribution Plan Disclosure [Line Items] Weighted average grant date fair value of options granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Gross Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost Conversion of preferred stock to common stock, shares Stock Issued During Period Shares Conversion Of Preferred Stock To Common Stock Stock issued during period shares conversion of Preferred Stock to Common Stock. One Year Anniversary [Member] Share-Based Payment Arrangement, Tranche One [Member] Statistical Measurement Statistical Measurement [Axis] Available-for-sale, investments in unrealized loss positions, less than twelve months, market value Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months Subsequent Event [Line Items] Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale, Total Maturities of available-for-sale investment securities Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale Income Tax [Table] Income Tax [Table] Income tax. Debt securities, available-for-sale, continuous unrealized loss position period. Debt Securities Available For Sale Continuous Unrealized Loss Position Period Available-for-sale investments gross unrealized loss positions, period Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance Stockholders' Equity Attributable to Noncontrolling Interest, Beginning Balance Stockholders' Equity Attributable to Noncontrolling Interest, Total Noncontrolling interest in Pangu BioPharma Limited Stockholders' Equity Attributable to Noncontrolling Interest Total assets Assets State [Member] State and Local Jurisdiction [Member] Percentage of participants's annual salary Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent Conversion of preferred stock to common stock Stock Issued During Period Value Conversion Of Preferred Stock To Common Stock Stock issued during period value conversion of Preferred Stock to Common Stock. Net loss per share - diluted Net loss Per Share, Diluted Net loss per share - diluted Numerator: Net Income (Loss) Available to Common Stockholders, Basic [Abstract] 2014 Plan [Member] Two Thousand Fourteen Stock Option Plan [Member] Two thousand fourteen stock option plan. Schedule of Potentially Dilutive Securities Not Included in Calculation of Diluted Net Loss Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Remaining receivable based on achievement of research milestones Remaining Amount Of Receivable Based On Achievement Of Research Milestones Remaining amount of receivable based on achievement of research milestones. Entity Address, Postal Zip Code Entity Address, Postal Zip Code Issuance of common stock from committed purchase agreement, net of offering costs, Shares Issuance Of Common Stock From Committed Purchase Agreement Net Of Offering Costs Shares Issuance of common stock from committed purchase agreement, net of offering costs in shares License and collaboration agreement revenue Revenue from Contract with Customer, Including Assessed Tax Additional allowance for tenant improvements Additional Allowance For Tenant Improvements Additional allowance for tenant improvements Document Fiscal Period Focus Document Fiscal Period Focus Organization, Business and Basis of Presentation Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Class Of Warrant Or Right [Table] Class of Warrant or Right [Table] Valuation allowance Valuation allowance Deferred Tax Assets, Valuation Allowance Preferred stock, $0.001 par value per share; 5,000,000 undesignated authorized shares as of December 31, 2022 and 2021, respectively; no shares issued or outstanding as of December 31, 2022 and 2021, respectively Preferred Stock, Value, Issued APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition 2027 Finance Lease, Liability, to be Paid, Year Five Counterparty Name Counterparty Name [Domain] Present value of lease payments Operating Lease, Liability Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Effective Income Tax Rate Reconciliation, Tax Contingency, Amount, Total Unrecognized tax benefits Effective Income Tax Rate Reconciliation, Tax Contingency, Amount Statement of Financial Position [Abstract] Entity File Number Securities Act File Number Scenario Scenario [Domain] Statement of Cash Flows [Abstract] 2028 and thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five Jefferies LLC. Jefferies L L C [Member] Jefferies LLC [Member] Class Of Warrant Or Right [Line Items] Class of Warrant or Right [Line Items] Geographical Geographical [Domain] Statistical Measurement Statistical Measurement [Domain] Statement of Stockholders' Equity [Abstract] Significant Accounting Policies [Table] Significant Accounting Policies [Table] Significant accounting policies. Sale of Stock Sale of Stock [Axis] Auditor Location Auditor Location Class of Stock Class of Stock [Domain] Collaborative agreement, funding received Collaborative Agreement Funding Received Collaborative agreement funding received. Subsequent Events [Abstract] Fair Value Measurements Fair Value Disclosures [Text Block] Weighted Average Contractual Term, Options Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Proceeds from Issuance of Common Stock Proceeds from Issuance of Common Stock Research and development credit carryforward Deferred Tax Assets, Tax Credit Carryforwards, Research Summary of Property and Equipment Property, Plant and Equipment [Table Text Block] Long-term purchase commitment, description Long-Term Purchase Commitment, Description Concentration of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Antidilutive Securities Antidilutive Securities [Axis] Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised, Total Proceeds from issuance of common stock through option exercises Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised Summary of Warrants Outstanding Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Preferred stock, par value Preferred Stock, Par or Stated Value Per Share Gross Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Balance Sheet Details Supplemental Balance Sheet Disclosures [Text Block] Subsequent Events Subsequent Events [Text Block] Shares used in computing net loss per share, diluted Weighted Average Number of Shares Outstanding, Diluted Weighted Average Number of Shares Outstanding, Diluted, Total State income taxes, net of federal benefit Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount Unrecognized share based compensation expense related to restricted stock units Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Corporate Debt Securities [Member] Corporate Debt Securities [Member] General and Administrative Expense [Member] General and Administrative Expense [Member] Issuance of common stock from underwritten follow-on offering, net of offering costs, Shares Issuance Of Common Stock From Underwritten Follow On Offering Net Of Offering Costs Shares Unrecognized share based compensation expense related to unvested stock options Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Commercial Paper [Member] Commercial Paper [Member] Expiration Date Class Of Warrant Or Rights Warrant Expiration Period Class of warrant or rights warrant expiration period. Current Fiscal Year End Date Current Fiscal Year End Date Investment Type Investment Type [Axis] License Agreement [Abstract] License agreement abstract. Financial Instruments Financial Instruments [Domain] 2015 Stock Option and Incentive Plan [Member] Two Thousand Fifteen Stock Option And Incentive Plan [Member] 2015 Stock Option and Incentive Plan. Lease extended maturity date Lease Extended Maturity Date Lease extended maturity date. Cash, cash equivalents and restricted cash at the end of period Cash, cash equivalents and restricted cash at end of period Cash, cash equivalents and restricted cash at beginning of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Other assets Other Assets, Noncurrent Total stockholders' equity Beginning balance Ending balance Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Entity Address, Address Line One Entity Address, Address Line One Noncontrolling Interest [Member] Noncontrolling Interest [Member] Document Annual Report Document Annual Report Summary of Assumptions Used to Determine Fair Value of Employee Stock Purchase Plan Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block] Transaction Type Transaction Type [Axis] Accrued Liabilities, Current [Abstract] Supplemental disclosure of cash flow information: Supplemental Cash Flow Information [Abstract] Investment Securities Investment, Policy [Policy Text Block] ATM Offering Program [Member] A T M Offering Program [Member] ATM offering program. Restricted cash Restricted cash at the end of period Restricted Cash, Noncurrent Income tax (benefit) provision Income tax (benefit) expense Income Tax Expense (Benefit) Operating lease liability Increase (Decrease) in Operating Lease Liability Weighted average common shares subject to repurchase Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation Weighted Average Exercise Price, Canceled/forfeited/expired Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Change in valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Description Of Business [Table] Description Of Business [Table] Description of business. Income Tax Income Tax Disclosure [Text Block] Vesting Vesting [Axis] Preferred stock, shares issued Preferred Stock, Shares Issued Balance Sheet Location Balance Sheet Location [Domain] Other accrued expenses Other Accrued Liabilities, Current Payments to Acquire Property, Plant, and Equipment, Total Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Income Tax Disclosure [Abstract] Commitment to purchase shares Long-Term Purchase Commitment, Amount Number of shares issued and sold Stock Issued During Period, Shares, New Issues Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Total Reserve and accruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals Other receivables Increase (Decrease) in Other Receivables Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Axis] Auditor Name Auditor Name Schedule Of Research And Development Arrangement Contract To Perform For Others [Table] Schedule of Research and Development Arrangement, Contract to Perform for Others [Table] Equity [Abstract] 2026 Finance Lease, Liability, to be Paid, Year Four Milestone payments received Milestone Payment Received Milestone payment received. Loss from operations Operating Income (Loss) Weighted average common shares outstanding Weighted Average Number of Shares Issued, Basic Collaboration Revenue [Member] Collaboration Revenue [Member] Collaboration revenue. Scenario Scenario [Axis] Research credits and other state credits Deferred Tax Assets Tax Credit Carryforwards Research And Other State Deferred tax assets, tax credit carryforwards, research and other state. Prepaid Manufacturing Expenses [Member] Prepaid Manufacturing Expenses [Member] Prepaid manufacturing expenses. Class of Warrant or Right Class of Warrant or Right [Domain] Entity Filer Category Entity Filer Category Allowance for tenant improvements Tenant Improvements Total operating expenses Operating Expenses Entity Current Reporting Status Entity Current Reporting Status Asset Class Asset Class [Domain] Stock compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Aggregate Intrinsic Value, Options Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Annual upward adjustments on base rate, percentage Annual Upward Adjustments on Base Rate Percentage Annual upward adjustments on base rate percentage. Available-for-sale investments Debt Securities, Available-for-Sale, Current Operating lease, lease not yet commenced, existence of option to extend Lessee, Operating Lease, Lease Not yet Commenced, Existence of Option to Extend [true false] Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments [Domain] Effective Income Tax Rate Reconciliation, Tax Settlement, Percent, Total Percentage of tax benefit to be realized upon settlement Effective Income Tax Rate Reconciliation, Tax Settlement, Percent Stockholders' Equity Attributable to Parent, Ending Balance Stockholders' Equity Attributable to Parent, Beginning Balance Total aTyr Pharma stockholders’ equity Stockholders' Equity Attributable to Parent Other Comprehensive Gain/(Loss) [Member] AOCI Attributable to Parent [Member] Short-term Investments Short-Term Investments [Member] Aspire Capital [Member] Aspire Capital [Member] Aspire capital member Asset Class Asset Class [Axis] Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Entity Tax Identification Number Entity Tax Identification Number Income Statement Location Income Statement Location [Axis] Common stock, $0.001 par value per share; 85,000,000 and 42,500,000 authorized shares as of December 31, 2022 and 2021, respectively; issued and outstanding shares - 29,498,488 and 27,793,035 as of December 31, 2022 and 2021, respectively Common Stock, Value, Issued Retained Earnings (Accumulated Deficit), Total Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Leased Equipment [Member] Equipment [Member] Foreign rate differential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount Other Comprehensive Gain/(Loss) [Member] Equity Components [Axis] Prepaid Expense, Current, Total Prepaid expenses Prepaid Expense, Current Debt Instruments [Abstract] Lease liability Deferred Tax Assets Lease Liability Deferred tax assets lease liability. Proceeds from issuance of common stock through employee stock purchase plan Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan Proceeds from issuance of common stock under employee stock purchase plan Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total Accounts payable and accrued expenses Increase (Decrease) in Accounts Payable and Accrued Liabilities Entity Emerging Growth Company Entity Emerging Growth Company Operating expenses: Operating Expenses [Abstract] ATM Offering Program [Member] At Market Offering Program [Member] At The Market Offering Program. Additional number of common stock shares reserved for issuance Additional Common Stock Capital Shares Reserved For Future Issuance Additional common stock capital shares reserved for future issuance. Kyorin Pharmaceutical Co Ltd [Member] Kyorin Pharmaceutical Co Ltd [Member] Kyorin pharmaceutical co ltd . Maximum term for stock option plan grant Stock Option Maximum Term Stock option maximum term. Revenue Recognition Revenue [Policy Text Block] Cost of Revenue, Total Stand-alone selling price of license Cost of Revenue Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Scientific and Laboratory Equipment [Member] Scientific And Laboratory Equipment [Member] Scientific and laboratory equipment. Transaction Transaction [Domain] Area of office and laboratory space Area of Real Estate Property Entity Voluntary Filers Entity Voluntary Filers Expected volatility, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Jones trading institutional services LLC Jones Trading Institutional Services L L C [Member] Jones Trading Institutional Services LLC [Member] Annual increase in shares authorized under plan, shares threshold Share-Based Compensation Arrangement by Share-Based Payment Award, Other Share Increase (Decrease) Retirement Benefits [Abstract] Document Transition Report Document Transition Report Total assets measured at fair value Assets, Fair Value Disclosure Purchases of property and equipment in accounts payable Purchases of Property and Equipment in Accounts Payable Purchases of property and equipment in accounts payable. Schedule of Pretax Losses for Domestic and Foreign Operations Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Weighted Average Grant Date Fair Value, Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Nonoperating Income (Expense), Total Total other income (expense), net Nonoperating Income (Expense) Depreciation, Depletion and Amortization, Total Depreciation expense Depreciation and amortization Depreciation, Depletion and Amortization Impairment, Long-Lived Asset, Held-for-Use, Total Impairment of long lived assets Impairment, Long-Lived Asset, Held-for-Use Silicon Valley Bank [Member] Silicon Valley Bank. Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Development Regulatory And Sales Milestones [Member] Development Regulatory And Sales Milestone [Member] Development regulatory and sales milestone member. Weighted Average Exercise Price, Exercises Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Foreign Income (Loss) from Continuing Operations before Income Taxes, Foreign Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Research And Development Arrangement Contract To Perform For Others [Line Items] Research and Development Arrangement, Contract to Perform for Others [Line Items] Warrant Four [Member] Warrant Four [Member] Warrant four. Date of Policy beginning Defined Contribution Plan Date Of Plan Beginning Defined contribution plan date of plan beginning. Warrant Three [Member] Warrant Three [Member] Warrant three. Net loss attributable to aTyr Pharma, Inc. Net loss attributable to aTyr Pharma, Inc. Net Income (Loss) Issuance of common stock from committed purchase agreement, net of offering costs Issuance Of Common Stock From Committed Purchase Agreement Net Of Offering Costs Issuance of common stock from committed purchase agreement, net of offering costs Available-for-sale, investments in unrealized loss positions, number of positions Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions Less: Current portion of operating lease liability Current portion of operating lease liability Operating Lease, Liability, Current Capitalized research and development expenses Deferred Tax Assets, in Process Research and Development Commitments and Contingencies [Line Items] Commitments and Contingencies Disclosure [Line Items] Commitments and contingencies disclosure. Schedule of Assets Measured at Fair Value on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Additional Paid-In Capital [Member] Additional Paid-in Capital [Member] Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Deferred Tax Assets, Operating Loss Carryforwards, Total Net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards Change in tax rate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount Entity Registrant Name Entity Registrant Name Cash and cash equivalents Cash and cash equivalents at the end of period Cash and Cash Equivalents, at Carrying Value, Total Cash and Cash Equivalents, at Carrying Value Summary of Assumptions Used to Determine Fair Value of Employee Stock Option Grants and Performance Options with Market Condition Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Class of Stock Class of Stock [Axis] Statement of Comprehensive Income [Abstract] Property and equipment, Net Property and equipment, net Property, Plant and Equipment, Net Weighted Average Contractual Term, Options Vested and Expected to Vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Award Type Award Type [Domain] Statement [Line Items] Statement [Line Items] Operating lease expense Operating Lease, Expense Weighted Average Exercise Price, Options Vested and Expected to Vest, Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Title of 12(b) Security Title of 12(b) Security Tenant Improvements [Member] Tenant Improvements [Member] Tenant improvements. Ownership Ownership [Domain] Common Stock [Member] Common Stock [Member] Restricted Cash Cash and Cash Equivalents and Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Equity Component Equity Component [Domain] Purchases of available-for-sale investment securities Payments to Acquire Debt Securities, Available-for-Sale Convertible Preferred Stock [Member] Convertible Preferred Stock Convertible Preferred Stock [Member] Revenue Total revenues Revenue from Contract with Customer, Excluding Assessed Tax Worldwide pre-tax loss Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Less: Amount representing interest Finance Lease, Liability, Undiscounted Excess Amount Entity Address, State or Province Entity Address, State or Province 2026 Lessee, Operating Lease, Liability, to be Paid, Year Four Geographical Geographical [Axis] Net change in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Comprehensive loss Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Document Type Document Type Interest paid Interest Paid, Excluding Capitalized Interest, Operating Activities Research credits Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount Entity Shell Company Entity Shell Company Number Outstanding Class of Warrant or Right, Outstanding Period of change in ownership Period Of Change In Ownership Period of change in ownership. Total stock-based compensation expense Stock-based compensation Share-Based Payment Arrangement, Expense Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Inducement Pool Non Qualified Option Inducement Pool Non Qualified Option [Member] Inducement pool non-qualified option. Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Fair Value, Recurring and Nonrecurring [Table] Security Exchange Name Security Exchange Name Revenues: Revenue from Contract with Customer [Abstract] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Long-term financing lease liability, net of current portion Finance Lease, Liability, Noncurrent Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Unrecognized cost expected to be recognized over a weighted average period Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Weighted Average Contractual Term, Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Other comprehensive loss: Other Comprehensive Income (Loss), Net of Tax [Abstract] Commitments and Contingencies Disclosure [Abstract] Proceeds from issuance of common stock from committed purchase agreement, net of offering costs Proceeds From Issuance Of Common Stock Through Committed Purchase Agreement Net Of Offering Costs Proceeds from issuance of common stock through committed purchase agreement net of offering costs. Restricted Stock Unit [Member] Restricted Stock Units (RSUs) [Member] Schedule of Activity Related to Unrecognized Tax Benefits Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] Principles of Consolidation Consolidation, Policy [Policy Text Block] 2024 Finance Lease, Liability, to be Paid, Year Two Schedule of Restricted Stock Units Activity Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Summary of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Majority-owned subsidiary percentage Noncontrolling Interest, Ownership Percentage by Parent Common Stock, Shares, Outstanding, Ending Balance Common Stock, Shares, Outstanding, Beginning Balance Common stock, shares outstanding Common Stock, Shares, Outstanding Base rent per square foot Base Rent Per Square Foot Base rent per square foot Amortization of premium of available-for-sale investment securities Accretion (Amortization) of Discounts and Premiums, Investments Significant Other Observable Inputs (Level 2) [Member] Fair Value, Inputs, Level 2 [Member] Market Value Debt Securities, Available-for-Sale, Total Aggregate value of investment securities Debt Securities, Available-for-Sale Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Increase related to current year tax positions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Commitments and contingencies (Note 6) Commitments and Contingencies Common stock, shares issued Common Stock, Shares, Issued Description Of Business [Line Items] Description Of Business [Line Items] Description of business. Minimum [Member] Minimum [Member] License, Collaboration and Other Agreements License Collaboration And Other Agreements [Text Block] Entire disclosure of license, collaboration and other agreements. Stock option grants description Share-Based Compensation Arrangement by Share-Based Payment Award, Description Shares Available Under the 2015 Plan [Member] Two Thousand Fifteen Stock Plan [Member] Two thousand fifteen stock plan. Agreed upon value of sale of common stock per transaction Common Stock, Value, Subscriptions Available-for-sale, investments in unrealized loss positions, greater than 12 months Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions Risk-free interest rate, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Leases Lessee, Leases [Policy Text Block] Weighted Average Exercise Price, Options Exercisable, Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price 401 (k) Plan [Member] Four Hundred One Plan [Member] Four hundred one plan. Tax Credit Carryforward Tax Credit Carryforward [Axis] Accrued expenses Accrued expenses Accrued Liabilities, Current Stockholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Schedule Of Available For Sale Securities [Table] Schedule of Available-for-Sale Securities [Table] Counterparty Name Counterparty Name [Axis] Entity Address, Address Line Two Entity Address, Address Line Two Amortization period of capitalized R&D costs Capitalized Research And Development Costs Amortization Period Capitalized research and development costs amortization period. Award Type Award Type [Axis] Subsequent Events [Member] Subsequent Event [Member] Issuance of common stock from registered direct offering, net of offering costs, Shares Stock Issued During Period Shares At Registered Direct Offering Net Of Offering Costs Stock issued during period shares at registered direct offering net of offering costs. Retirement Plan Name Retirement Plan Name [Domain] Total tax assets Deferred Tax Assets, Gross Impairment of Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Aggregate intrinsic value of stock options exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Issuance Of Common Stock From Underwritten Follow On Offering Net Of Offering Costs Issuance of common stock from underwritten follow-on offering, net of offering costs Issuance Of Common Stock From Underwritten Follow On Offering Net Of Offering Costs Capitalization of R&D costs Research and Development Expense, Total Research and development Research and Development Expense Financing lease, term of contract Lessee, Finance Lease, Term of Contract Warrant Five [Member] Warrant Five [Member] Warrant five. Patent Costs Legal Costs, Policy [Policy Text Block] Intangible assets Deferred Tax Assets, Goodwill and Intangible Assets Entity Central Index Key Entity Central Index Key Cowen Company, LLC (Cowen) [Member] Jones Trading [Member] Jones trading. Accounting Policies [Abstract] Investments, Debt and Equity Securities [Abstract] Proceeds from issuance of common stock from at-the-market offerings, net of offering costs Proceeds From Issuance Of Common Stock Through At Market Offering Net Of Offering Costs Proceeds from issuance of common stock through at market offering net of offering costs. Issuance of common stock from registered direct offering, net of offering costs Stock Issued During Period Value At Registered Direct Offering Net Of Offering Costs Stock issued during period value at registered direct offering net of offering costs. Schedule of Available-for-sale Securities [Line Items] Debt Securities, Available-for-Sale [Line Items] Financing lease, right-of-use assets Finance Lease, Right-of-Use Asset, after Accumulated Amortization Finance Lease, Right-of-Use Asset, after Accumulated Amortization, Total Shares issued, price per share Stock Issued During Period Additional Share Of Common Stock1 Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total Less accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Schedule Of Property Plant And Equipment [Table] Property, Plant and Equipment [Table] Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract] Financing lease, weighted-average discount rate Finance Lease, Weighted Average Discount Rate, Percent Aggregate intrinsic value of restricted stock units Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Measurement Frequency Measurement Frequency [Axis] NOLs carryforwards expiration year Operating Loss Carryforwards Expiration Year Operating loss carryforwards expiration year. NOLs carryforwards subject to expiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration Purchase of fixed assets included in accounts payable Purchases Of Fixed Assets Included In Accounts Payable Purchases of fixed assets included in accounts payable. Class X Preferred Stock (if-converted to common stock) [Member] Class X Convertible Preferred Stock If Converted [Member] Class X convertible preferred stock (if-converted). Aggregate Intrinsic Value, Options Vested and Expected to Vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Subsequent Event [Table] General and Administrative Expense, Total General and administrative General and Administrative Expense Purchase Agreement [Member] Purchase Agreement [Member] Purchase Agreement Member. Weighted Average Exercise Price, Beginning Balance Weighted Average Exercise Price, Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Principal paid on finance lease liabilities Finance Lease, Principal Payments Research and Development Expense [Member] Research and Development Expense [Member] Risk-free interest rate, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Schedule of Future Minimum Payments under Non-cancelable Operating Lease and Reconciliation to Operating Lease Liability Schedule Of Future Minimum Rental Payments For Operating Lease Table [Text Block] Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating lease. Right-of-use assets obtained in exchange for lease obligation Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Research and development credit carryforward expiration year Deferred Tax Assets Tax Credit Carryforwards Research Expiration Year Deferred tax assets, tax credit carryforwards, research expiration year. Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Accumulated Deficit [Member] Retained Earnings [Member] Security deposit Security Deposit Commission rate equal to gross proceeds Commission Rate Equal To Gross Proceeds Commission rate equal to gross proceeds Tax Credit Carryforward, Name Tax Credit Carryforward, Name [Domain] Prepaid Expense, Current [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Gain (loss) on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment, Total Gain (Loss) on Disposition of Property Plant Equipment Issuance of common stock from at the market offerings, net of offering costs, Shares Stock Issued During Period Shares At The Market Offerings Net Of Offering Costs Stock issued during period shares at the market offerings net of offering costs. Property, Plant and Equipment, Gross, Ending Balance Property, Plant and Equipment, Gross, Beginning Balance Property, Plant and Equipment, Gross, Total Property and equipment, Gross Property, Plant and Equipment, Gross Option vesting percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Additional Paid in Capital, Total Additional paid-in capital Additional Paid in Capital Expenses Costs and Expenses, Related Party Entity Interactive Data Current Entity Interactive Data Current Operating lease, lease not yet commenced, term of contract Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract Issuance of common stock from at-the-market offerings, net of offering costs Stock Issued During Period Value At The Market Offerings Net Of Offering Costs Stock issued during period value at the market offerings net of offering costs. Entity Public Float Entity Public Float Number of Outstanding Stock Options, Vested and Expected to Vest, Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Warrant One [Member] Warrant One [Member] Warrant one. 2023 Lessee, Operating Lease, Liability, to be Paid, Year One Accrued clinical and manufacturing Accrued Clinical Studies Costs Accrued clinical studies costs. Available-for-sale, investments in unrealized loss positions, greater than twelve months, market value Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer Local Phone Number Local Phone Number Debt discount accretion and non-cash interest expense Accretion Expense Balance as of beginning of year Balance as of end of year Unrecognized Tax Benefits Current cash, cash equivalents, restricted cash and available-for-sale investments percentage Current Cash, Cash Equivalents, Restricted Cash and Available for Sale Investments Current cash, cash equivalents, restricted cash and available for sale investments. Summary of Net Loss Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Options vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Net Income (Loss) Attributable to Noncontrolling Interest, Total Net loss attributable to noncontrolling interest in Pangu BioPharma Limited Net Income (Loss) Attributable to Noncontrolling Interest Policy approved month and year Defined Contribution Plan Approved Month And Year Defined contribution plan approved month and year. Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Organization and Business Basis of Accounting, Policy [Policy Text Block] Number of Outstanding Stock Options, Exercisable, Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Warrants and Rights Note Disclosure [Abstract] IPO [Member] IPO [Member] Municipal Bonds [Member] Municipal Bonds [Member] Lease, option to extend Lessee, Operating Lease, Existence of Option to Extend [true false] Number of Outstanding Stock Options, Granted Stock options granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Income Statement Location Income Statement Location [Domain] Significant Accounting Policies [Line Items] Significant Accounting Policies [Line Items] Significant account policies line items. Property, Plant and Equipment [Abstract] Pangu BioPharma [Member] Pangu Bio Pharma Limited [Member] Pangu BioPharma Limited. Change in unrecognized tax benefits Increase in Unrecognized Tax Benefits is Reasonably Possible Number of Outstanding Restricted Stock Units, Beginning Balance Number of Outstanding Restricted Stock Units, Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Beginning balance, Shares Ending balance, Shares Shares, Outstanding Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Gross proceeds from market offering Gross Proceeds From Market Offering Gross proceeds from market offering. Shares Available Under the Employee Stock Purchase Plan [Member] Employee Stock Purchase Plan [Member] Employee Stock Purchase Plan [Member] Employee stock purchase plan. Number of Outstanding Stock Options, Ending Balance Number of Outstanding Stock Options, Beginning Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Document Fiscal Year Focus Document Fiscal Year Focus Number of Outstanding Restricted Stock Units, Released Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Released In Period Share based compensation arrangement by share based payment award, equity instruments other than options, released in period. Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total Unrecognized tax benefits, income tax penalties and interest accrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Repayments on borrowings Repayments of Debt Class of Warrant or Right Class of Warrant or Right [Axis] Options vesting period, description Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights 2024 Lessee, Operating Lease, Liability, to be Paid, Year Two Vesting Vesting [Domain] Net loss per share - basic Net loss per share - basic Earnings Per Share, Basic Two thousand twenty two inducement plan. Two Thousand Twenty Two Inducement Plan [Member] Shares Available Under the 2022 Inducement Plan [Member] Employee Benefits Compensation and Employee Benefit Plans [Text Block] Assets Assets [Abstract] Investments, Fair Value Disclosure, Total Investments, fair value Investments, Fair Value Disclosure Net deferred tax assets Deferred Tax Assets, Net Expected volatility, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Shares Issued, Price Per Share Shares Issued, Price Per Share Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount, Total Permanent items and other Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount Financial Instrument Financial Instrument [Axis] Long-Lived Tangible Asset Long-Lived Tangible Asset [Axis] Balance Sheet Details [Abstract] Balance sheet details. Stockholders' Equity Shareholders' Equity and Share-Based Payments [Text Block] Liabilities and Stockholders’ Equity Liabilities and Equity [Abstract] Cash equivalents, available-for-sale investments and restricted cash Cash And Cash Equivalents Restricted Cash And Available For Sale Investments Cash and cash equivalents restricted cash and available for sale investments. Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Antidilutive Securities, Name Antidilutive Securities, Name [Domain] Available-for-sale [Member] Available-for-Sale Securities [Member] Income Tax Authority Income Tax Authority [Axis] Total deferred tax assets Deferred Tax Assets, Net of Valuation Allowance Preferred Stock Preferred Stock [Member] Net loss Consolidated net loss Consolidated net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Sale Agreement [Member] Sales Agreement [Member] Sales agreement. Current assets: Assets, Current [Abstract] Prepaid Expenses [Line Items] Prepaid Expenses [Line Items] Prepaid Expenses [Line Items] Exercise Price Per Share Class of Warrant or Right, Exercise Price of Warrants or Rights Schedule of Significant Components of Deferred Tax Assets Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Domain] Discretionary contribution Defined Contribution Plan, Employer Discretionary Contribution Amount Class X Convertible Preferred Stock [Member] Class X Convertible Preferred Stock [Member] Class X convertible preferred stock. Measurement Frequency Measurement Frequency [Domain] Percentage of change in ownership Percentage Of Change In Ownership Percentage of change in ownership. Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] United States Income (Loss) from Continuing Operations before Income Taxes, Domestic Cover [Abstract] Impairment charges on investment securities Other-than-temporary Impairment Loss, Debt Securities, Available-for-Sale Product and Service Product and Service [Domain] 2027 Lessee, Operating Lease, Liability, to be Paid, Year Five Commitments and Contingencies Debt Commitments And Contingencies [Text Block] Debt commitments and contingencies. Current liabilities: Liabilities, Current [Abstract] Maximum [Member] Maximum [Member] Maximum [Member] Percentage of match employee contribution Defined Contribution Plan, Employer Matching Contribution, Percent of Match Net unrealized loss on investments, net of tax Change in unrealized loss on available-for-sale investments, net of tax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Retirement Plan Name Retirement Plan Name [Axis] H.C. Wainwright & Co., LLC [Member] H C Wainwright Co L L C [Member] H.C. Wainwright & Co., LLC Member. Net cash (used in) provided by investing activities Net Cash Provided by (Used in) Investing Activities Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Lease extended maturity Term Lease extended maturity term. Number of Outstanding Stock Options, Exercises Exercises Issuance of common stock upon exercise of stock options, Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Orphan Drug Credits [Member] General Business Tax Credit Carryforward [Member] Income Tax [Line Items] Income Tax [Line Items] Income tax. Significant Unobservable Inputs (Level 3) [Member] Fair Value, Inputs, Level 3 [Member] Schedule of Allocation of Stock-Based Compensation for All Options Including Performance Options with Market Condition and Restricted Stock Units Share-Based Payment Arrangement, Cost by Plan [Table Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Available-for-sale investments effective maturity period Available For Sale Securities Effective Maturity Period Available for sale securities effective maturity period. Long-term purchase commitment, period Long-Term Purchase Commitment, Period Issuance of common stock upon exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Segment Reporting Segment Reporting, Policy [Policy Text Block] Estimated useful life of property and equipment Property, Plant and Equipment, Useful Life Accrued Expenses Accrued Expenses Policy [Text Block] accrued expenses. Foreign [Member] Foreign Tax Authority [Member] Deferred tax assets: Deferred Tax Assets, Net [Abstract] Common stock, shares authorized Common Stock, Shares Authorized Trading Symbol Trading Symbol Ownership Ownership [Axis] Defined Contribution Plan [Table] Defined Contribution Plan [Table] Upfront payment received Upfront Payment Received Upfront payment received. Schedule of Available-for-sale Investments Debt Securities, Available-for-Sale [Table Text Block] Funding of project cost, description. Funding of project cost, description Funding Of Project Cost Description Public Offerings [Member] Public Offerings [Member] Public offerings member. Subsequent Event Type [Axis] Amortization of right-of-use assets Operating Lease, Right-of-Use Asset, Amortization Expense Debt Security Category Debt Security Category [Axis] Balance Sheet Location Balance Sheet Location [Axis] Comprehensive loss attributable to aTyr Pharma, Inc. common stockholders Comprehensive Income (Loss), Net of Tax, Attributable to Parent Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Proceeds from Sale of Property, Plant, and Equipment, Total Proceeds from sale of property and equipment Proceeds from Sale of Property, Plant, and Equipment Accounts Payable, Current, Total Accounts payable Accounts Payable, Current Prepaid Expenses [Table] Prepaid Expenses [Table] Prepaid Expenses [Table] Gross Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Gross proceeds from agreement Gross Proceeds From Agreements Gross proceeds from agreements. Plan Name Plan Name [Axis] Expected income taxes benefit at federal statutory rate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount Long-Lived Tangible Asset Long-Lived Tangible Asset [Domain] Common stock, par value Common Stock, Par or Stated Value Per Share Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Capitalized R&D costs Research And Development Costs Capitalized Research and development costs capitalized. Operating lease, lease not yet commenced, option to extend Lessee, Operating Lease, Lease Not yet Commenced, Option to Extend Number of Outstanding Restricted Stock Units, Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Computer and Office Equipment [Member] Computer And Office Equipment [Member] Computer and office equipment. Weighted average exercise price, granted Weighted Average Exercise Price, Granted Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Share-based compensation arrangements by share-based payment award, options, grants in period exercise price. Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Exercise Price Exercise price, granted Anti-dilutive securities not included in calculation of diluted net loss per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Schedule of Future Minimum Payments under Non-cancelable Financing Lease and Reconciliation to Financing Lease Liability Finance Lease, Liability, Fiscal Year Maturity [Table Text Block] Available for sale investments number of positions Available for Sale Investments Number of Positions Available for sale investments number of positions. Additional Collaboration Revenue [Member] Additional Collaboration Revenue [Member] Additional collaboration revenue.